Leisha Emens

Associate Professor

1992 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Cancer Vaccines Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Vaccines Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2018

Breast cancer immunotherapy: Facts and hopes

Emens, L. A. Feb 1 2018 In : Clinical Cancer Research. 24, 3, p. 511-520 10 p.

Research output: Contribution to journalReview article

Immunotherapy
Breast Neoplasms
CD274 Antigen
Biomarkers
Triple Negative Breast Neoplasms

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy

Hung, C. F., Xu, X., Li, L., Ma, Y., Jin, Q., Viley, A., Allen, C., Natarajan, P., Shivakumar, R., Peshwa, M. V. & Emens, L. A. May 1 2018 In : Human Gene Therapy. 29, 5, p. 614-625 12 p.

Research output: Contribution to journalArticle

Antigen Receptors
Human Development
Ovarian Neoplasms
Lymphocytes
Messenger RNA

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H. L., Rosner, G. L., Jeter, S. C., Armstrong, D., Emens, L. A., Fetting, J., Wolff, A. C., Silhy, R., Stearns, V. & Connolly, R. M. Jan 1 2018 (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Confidence Intervals
Stroke Volume
Incidence

The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome

Arias-Pulido, H., Cimino-Mathews, A., Chaher, N., Qualls, C., Joste, N., Colpaert, C., Marotti, J. D., Foisey, M., Prossnitz, E. R., Emens, L. A. & Fiering, S. Jun 1 2018 (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-10 10 p.

Research output: Contribution to journalArticle

Inflammatory Breast Neoplasms
Tumor-Infiltrating Lymphocytes
B-Lymphocytes
Stromal Cells
Triple Negative Breast Neoplasms
Tumor Microenvironment
Macrophages
Neoplasms
Ovarian epithelial cancer
Recurrence